Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 62,597 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS | 8,333 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS | 12,553 | $221.50 | $2.8M | -60.1% | Open the original filing on SEC.gov |
| Dec 29, 2025 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 450 | — | — | -2.1% | Open the original filing on SEC.gov |
| Dec 10, 2025 | CDTX | Cidara Therapeutics, Inc. | FTAX | 10,332 | $219.60 | $2.3M | -32.7% | Open the original filing on SEC.gov |